Cardiology

Abelacimab reduces bleeding risk in atrial fibrillation patients, even with kidney disease, study finds.

Learn if post-heart attack H. pylori screening prevents gastrointestinal bleeding and who might benefit. Keep reading for insights.

Women remain underrepresented in heart trials, a global review finds, risking gaps in tailored cardiovascular care and outcomes.

Find out how app-based messaging supports diabetes management and reduces cardiovascular risks in adults with poor control. Keep reading.

AF screening with an ECG patch led to a modest increase in AF diagnosis at 2.5 years

Understand how chamber volume ratios on MRI predict cardiac risk, even when heart chambers fall within normal size limits.

The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy.

In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients.